Skip to content

Cart (0)

Nothing in here yet.

Thirty strips to a tin, and the amounts are printed on the back.

Look at the strips

    On a GLP-1? The Nutrient Gaps Ozempic and Wegovy Leave Behind

    Abstract visualization of nutrient particles dispersing from a dissolving medication capsule shape against a gradient background representing nutritional depletion

    The GLP-1 Weight-Loss Effect Nobody Talks About

    If you're on semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), you already know about the nausea, the smaller appetite, and the weight on the scale going down. What your prescriber may not have mentioned: the nutrients going down with it. A 2026 narrative analysis covering 480,825 adults found that vitamin D deficiency affected 7.5% of GLP-1 users at six months and 13.6% at twelve months, while more than 60% consumed less than estimated requirements for calcium and iron (Urbina et al., Clinical Obesity, 2026). That's not a side effect most people plan for.

    What the Research Says About GLP-1s and Nutrient Gaps

    GLP-1 receptor agonists work partly by slowing gastric emptying and reducing appetite — both of which lower the total volume of food you eat each day. Less food means fewer vitamins and minerals coming in. A study of 2,031 adolescents aged 10–17 on GLP-1 medications found that nearly 1 in 6 (16.8%) were diagnosed with a nutritional deficiency within their first year of treatment, with vitamin D accounting for 12.4% of those diagnoses (Kerr et al., Childhood Obesity, 2026, Lurie Children's Hospital / Northwestern University). And that's in a population where deficiency screening is more routine than it is in adults.

    The mechanisms layer on top of each other. Reduced food intake means fewer B12-rich foods like meat, fish, and dairy. Some evidence suggests GLP-1 agonists may lower gastric acid production, which matters because stomach acid is required to release B12 from food proteins so it can bind intrinsic factor. And the GI side effects — 44% of patients taking semaglutide 2.4 mg reported nausea in the STEP program trials, with 24% experiencing vomiting — make it harder to keep down the food you do eat (Wharton et al., Diabetes, Obesity and Metabolism, 2022).

    The Five Nutrients Most at Risk

    Not every vitamin is equally vulnerable. The research points to a specific cluster of nutrients that GLP-1 users need to watch. Here's what the data shows, and what you can do about each one.

    Vitamin D

    Vitamin D deficiency was the most common finding across multiple studies — 7.5% at six months, climbing to 13.6% at twelve months in the Urbina analysis. This matters beyond bone health: vitamin D supports immune function, mood regulation, and how your body uses calcium. If you're eating less and spending more time indoors (a common pattern during GLP-1 adjustment), the deficit compounds fast.

    Vitamin B12

    B12 depends on a complex uptake chain that starts with stomach acid and intrinsic factor. GLP-1 medications may interfere with both. The risk increases if you're already on a PPI (proton pump inhibitor) or metformin — medications that on their own deplete B12. Symptoms like fatigue, brain fog, and tingling in the hands often get attributed to the medication itself when the real culprit is a nutrient gap.

    Iron

    The Urbina analysis found ferritin levels 26–30% lower in GLP-1 users compared to SGLT2 comparators, and more than 60% of patients consumed less than estimated iron requirements. Iron is already one of the harder nutrients to get from food alone — it competes with calcium for the same transport pathways, and the GI distress that comes with GLP-1s makes iron-rich red meat less appealing (and harder to tolerate).

    Calcium

    Calcium intake drops when food volume drops. A retrospective cohort of 255 patients found bone mineral density declined at the lumbar spine (−1.6%), femoral neck (−1.8%), and total hip (−2.8%) after starting GLP-1 therapy, with 13% of patients experiencing a new fracture (Liu et al., 2025 Endocrine Society abstract). Rapid weight loss amplifies the effect — bone mineral density loss tracked with weight loss in that study (Pearson r = 0.35, P < .001).

    Protein (and the Lean Mass Problem)

    This one isn't a micronutrient, but it may be the most consequential. A systematic analysis of 22 randomized controlled trials (2,258 participants) found that about 25% of total weight lost with GLP-1 and dual GIP/GLP-1 agonists was lean mass (Noronha et al.). Landmark trials put the figure at 26–40% of total weight lost. An expert consensus commentary compared the muscle loss to what typically occurs over a decade or more of aging. The research is clear: higher protein intake — more than 1.2 g/kg/day, spread evenly across meals — combined with resistance training can significantly reduce lean mass loss.

    Why the Nausea Problem Is a Supplement Problem

    Here's the part that creates a cruel paradox: the people who most need nutritional support are often the least able to take traditional supplements. With 44% of semaglutide users reporting nausea and 24% reporting vomiting, swallowing a handful of pills every morning becomes a genuine challenge. The GI symptoms affect around 40% of patients and are the leading cause of GLP-1 discontinuation.

    This isn't just about comfort. A study by Kerr et al. at Lurie Children's Hospital found that only 5% of GLP-1 users received nutritional counseling within 30 days of starting treatment, and fewer than 25% received it within six months. The supplement gap isn't just biochemical — it's structural. People aren't being told which nutrients to watch, and even when they are, the format they're told to take (pills) is the one their body is most likely to reject.

    What XYNE Strips Can (and Can't) Do Here

    We make dissolvable supplement strips that dissolve in about 30 seconds — no water, no pills, nothing to swallow. For someone dealing with GLP-1-related nausea, that format difference matters practically: you don't need to keep a pill down when there's no pill to swallow.

    Our Bone Support Strips deliver vitamin D3 and calcium in a format that sidesteps the swallowing problem. Our Iron Strips deliver 19 mg of iron on a raspberry strip — nothing to swallow, no water needed. Traditional iron supplements cause GI side effects in 30–40% of users even without a GLP-1 on board (Tolkien et al., PLOS ONE, 2015), which is part of why iron compliance is notoriously low.

    Every active, with its amount — no proprietary blends. We include an honest section in every article about when a different format is the better choice. And we're going to do that right now.

    When Pills Still Win (Even if They're Harder to Take)

    Strips have a dose ceiling. A thin film can hold milligrams of an ingredient, not grams. That means certain nutrients that GLP-1 users need simply require more payload than a strip can deliver.

    • Protein powder: You need 1.2+ g/kg/day to protect lean mass. That means food, shakes, or powder — this is the single most important intervention for GLP-1 users.
    • Magnesium: Therapeutic doses start at 200–400 mg. A strip can't carry that much. A capsule or powder is the right call.
    • Omega-3 fatty acids: Effective EPA/DHA doses run 1,000–2,000 mg. That's a softgel or liquid, period.
    • Fiber: The mechanism IS the bulk. You need the physical volume. A powder mixed into food or liquid is the only supplement format that makes sense here.

    If someone is selling you a single product that claims to solve all GLP-1-related nutrient gaps, be skeptical. The gaps are too diverse and the doses too varied for any one format to handle everything.

    When to See a Doctor Instead of Shopping for Supplements

    Supplements support a routine. They don't replace medical care. Talk to your healthcare provider before adding or changing supplements, especially if you're on prescription GLP-1 medication. And see your doctor if you notice any of the following:

    • Persistent fatigue, brain fog, or tingling/numbness — these can signal B12 or iron deficiency that may need testing and treatment beyond supplementation.
    • Hair loss, brittle nails, or unusual bruising — possible signs of multiple nutrient deficiencies developing simultaneously.
    • Muscle weakness or difficulty with tasks that used to be easy — lean mass loss can accelerate quickly, especially in older adults and women (ENDO 2025 conference data linked older age and female sex to greater muscle loss on semaglutide).
    • Bone pain or a fracture from a minor fall — GLP-1-associated bone density loss is dose-dependent and correlated with the degree of weight loss.
    • GI symptoms severe enough that you can't keep food down — 4.3% of patients in the STEP 1–3 trials discontinued treatment due to GI side effects. If eating is a struggle, supplements alone can't compensate for the caloric and nutrient deficit.

    Building a GLP-1 Support Routine That Actually Works

    There's no one-size-fits-all protocol, but the research points to a practical framework. Start with the foundations — protein, resistance training, and bloodwork — then layer targeted supplementation where the data supports it.

    1. Get baseline bloodwork. Before or shortly after starting a GLP-1, test vitamin D (25-hydroxyvitamin D), B12, ferritin, and a comprehensive metabolic panel. You can't fix what you don't measure.
    2. Prioritize protein. More than 1.2 g/kg/day, spread across meals. In a 3-year study of adults aged 70–79, the highest protein-intake quintile lost about 40% less lean mass than the lowest. Evenly distributed protein increased muscle protein synthesis by 25% versus a skewed eating pattern.
    3. Add resistance training. Exercise combined with GLP-1 therapy produced the greatest weight loss while preserving lean mass in multiple studies. This is non-negotiable if you care about keeping muscle.
    4. Supplement the documented gaps. Vitamin D, B12, and iron are the three with the strongest evidence base in GLP-1 populations. Choose formats you'll actually take — consistency matters more than any single dose.
    5. Retest at 6 and 12 months. The Urbina analysis showed deficiency rates nearly doubling between 6 and 12 months. Your nutrient needs are a moving target on these medications.

    Frequently Asked Questions

    Does Ozempic or Wegovy cause vitamin deficiencies?

    Research suggests GLP-1 medications like semaglutide increase the risk of nutrient gaps, particularly in vitamin D, B12, iron, and calcium. A 2026 analysis of 480,825 adults found vitamin D deficiency rose from 7.5% at six months to 13.6% at twelve months of GLP-1 use (Urbina et al., Clinical Obesity). The mechanism involves reduced food intake, possible changes in gastric acid production, and GI side effects that make nutrient-dense foods harder to tolerate.

    What supplements should I take while on a GLP-1 medication?

    The most evidence-supported supplements for GLP-1 users are vitamin D, vitamin B12, and iron — the three nutrients with the strongest documented depletion data. Calcium and protein are also critical, though protein needs (1.2+ g/kg/day) typically require food or powder rather than a supplement. Always discuss new supplements with your prescriber, especially because GLP-1 medications can change how your body processes what you take.

    Can I take vitamins while on semaglutide if I feel nauseous?

    Yes, but format matters. With 44% of semaglutide users experiencing nausea, traditional pills can be difficult to tolerate. Dissolvable formats like strips avoid the swallowing problem entirely — they dissolve in about 30 seconds with no water needed. Liquid vitamins and sublingual drops are other options that avoid the pill-swallowing problem. Whatever format you choose, consistency is more important than timing.

    Does GLP-1 medication affect bone density?

    Emerging research shows a correlation between GLP-1-associated weight loss and bone mineral density decline. A retrospective study of 255 patients found BMD declined at the lumbar spine (−1.6%), femoral neck (−1.8%), and total hip (−2.8%), with 13% experiencing a new fracture (Liu et al., 2025 Endocrine Society). Researchers believe the bone loss is driven primarily by the degree of weight loss rather than the medication alone, which makes adequate calcium, vitamin D, and weight-bearing exercise especially important.

    How much muscle do you lose on Ozempic or Wegovy?

    A systematic analysis of 22 RCTs found that approximately 25% of total weight lost on GLP-1 medications was lean mass, with some landmark trials reporting 26–40%. Older adults and women may be more vulnerable. The most effective protection is a combination of adequate protein intake (more than 1.2 g/kg/day), resistance training, and gradual dose titration. In clinical studies, patients who combined exercise with GLP-1 therapy achieved the greatest weight loss while best preserving lean tissue.

    Related Reading

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Keep reading

    Every amount is on the label.

    Eleven formulas, every active printed with its amount, and no proprietary blends. Read a label before you read another post.

    See the formulas